Well well no surprise, I was just wondering when Nox would put out another ASX Ann about somebody else’s study, and I see they’ve pulled the trigger immediately. And of course we see the same big efficacy claims for Nox drug beyond what’s offered by Novartis Lu.
Pharma companies can be very sensitive - wonder if their legal/ governance teams in Basel are ok with another company talking about their as yet unpublished results for the obvious benefit of the company making the public release. Interesting thought that crossed my mind.
Novartis Vision trial result, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.015(14.3%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 12.0¢ | 10.5¢ | $28.47K | 247.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4392 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 57055 | 4 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |